Nomura Holdings’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,328,291
| Closed | -$15.2M | – | 920 |
|
|
2022
Q4 | $15.2M | Buy |
1,328,291
+1,044,484
| +368% | +$12M | 0.06% | 99 |
|
|
2022
Q3 | $3.57M | Buy |
+283,807
| New | +$3.57M | 0.01% | 361 |
|
|
2014
Q2 | – | Sell |
-13,448
| Closed | -$142K | – | 1919 |
|
|
2014
Q1 | $142K | Buy |
+13,448
| New | +$142K | ﹤0.01% | 1695 |
|
|
2013
Q4 | – | Sell |
-92,836
| Closed | -$677K | – | 1887 |
|
|
2013
Q3 | $677K | Buy |
92,836
+74,884
| +417% | +$546K | ﹤0.01% | 1145 |
|
|
2013
Q2 | $28K | Buy |
+17,952
| New | +$28K | ﹤0.01% | 2033 |
|